Amanta Healthcare Limited (NSE:AMANTA)

India · Delayed Price · Currency is INR

150.27

-6.87 (-4.37%)

At close: Jun 16, 2026

11.31% (1Y)

Market Cap	5.16B
Revenue (ttm)	2.88B +4.7%
Net Income	148.75M +41.7%
EPS	4.33 +16.7%
Shares Out	34.34M
PE Ratio	34.70
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	381,827
Open	157.00
Previous Close	157.14
Day's Range	146.00 - 157.94
52-Week Range	92.00 - 164.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 31, 2026

About Amanta Healthcare

Amanta Healthcare Limited operates as a pharmaceutical company engaged in developing, manufacturing and marketing a diverse range of sterile liquid products and parenteral products in Africa, Latin America, the United Kingdom, and internationally. The company manufactures its products in three product group segments Large Volume Parenteral, Nipple Head (Single Port), SteriPort (Two Ports), and Small Volume Parenteral. Additionally, it manufactures medical devices and fluid therapy - (IV Fluid), formulations, diluents, ophthalmic, respiratory ca... [Read more]

Industry Pharmaceutical Preparations

Founded 1994

Employees 522

Stock Exchange National Stock Exchange of India

Ticker Symbol AMANTA

Full Company Profile

Financial Performance

In fiscal year 2026, Amanta Healthcare's revenue was 2.88 billion, an increase of 4.72% compared to the previous year's 2.75 billion. Earnings were 148.75 million, an increase of 41.66%.

Financial Statements